Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vascular ; : 17085381241236575, 2024 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-38391289

RESUMEN

INTRODUCTION: Thoracic aortic aneurysms (TAAs) are an increasingly prevalent pathology with significant associated morbidity and mortality. Thoracic endovascular aortic repair (TEVAR) is the primary line of treatment. The purpose of this study was to analyse a single center's experience in the treatment of TAAs and identify possible risk factors for worse outcomes. METHODS: A retrospective review of our institutional database was done to identify all patients treated for TAAs in a 10-year period, from 1 January 2012 to 31 December 2022. Data were extracted from patients' medical records. Primary outcome was all-cause mortality and secondary outcomes were procedure related morbidity (vascular access complications, medullary ischaemia, stroke, endoleaks, migration, aneurysm sac enlargement >5 mm) and need for reintervention at 1-, 6- and 12-month follow-up. A descriptive and inferential analysis of the data was performed. Statistical analyses were conducted using the IBM Statistical Package for Social Sciences (SPSS) software. RESULTS: We identified 34 patients treated for TAAs in this period. Mean age was 68 years [47-87] and 79.4% of patients were male. Mean aneurysm diameter was 63 mm [35-100], 55.9% fusiform and 44.1% saccular. The majority (91.2%) were located at the descending thoracic aorta and 3 (8.8%) of them extended to the aortic arch. The most common aetiology was degenerative in 22 patients (64.7%), followed by aortic dissection in 8 patients (23.5%). Elective surgery was performed in 19 (61.3%) patients and 12 (38.7%) had urgent repair. TEVAR was the treatment of choice in 24 (77.4%) patients, and the remaining 7 (22.6%) were treated with hybrid surgery. Mean length of hospital stay was 10 days [2-80] (6 days for elective repair versus 16 days for urgent repair, p = .016). Follow-up period ranged from 1 month to 10 years. At 1 year follow-up, all-cause mortality was 15%, morbidity was 30% (with 6 (22%) patients having a type Ia endoleak) and need for reintervention was 22%. Aneurysm diameter was a significant risk factor for procedure related morbidity (median diameter of 73.5 mm versus 56.0 mm in patients with no morbidity; p = .027). The presence of type Ia endoleak was significantly associated with higher reintervention rates (p = .001), but not with higher mortality rates (p = .515). Age, female sex, aetiology and urgent repair weren't associated with any significant differences in the outcomes. CONCLUSIONS: TEVAR proved to be effective in the treatment of TAAs, with good outcomes at short and mid-term follow-up. TAAs should be diagnosed earlier and be promptly treated when meeting criteria to prevent worse outcomes.

2.
Nat Med ; 29(10): 2509-2517, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37696933

RESUMEN

Pathogen genome sequencing during epidemics enhances our ability to identify and understand suspected clusters and investigate their relationships. Here, we combine genomic and epidemiological data of the 2022 mpox outbreak to better understand early viral spread, diversification and transmission dynamics. By sequencing 52% of the confirmed cases in Portugal, we identified the mpox virus sublineages with the highest impact on case numbers and fitted them into a global context, finding evidence that several international sublineages probably emerged or spread early in Portugal. We estimated a 62% infection reporting rate and that 1.3% of the population of men who have sex with men in Portugal were infected. We infer the critical role played by sexual networks and superspreader gatherings, such as sauna attendance, in the dissemination of mpox virus. Overall, our findings highlight genomic epidemiology as a tool for the real-time monitoring and control of mpox epidemics, and can guide future vaccine policy in a highly susceptible population.


Asunto(s)
Mpox , Minorías Sexuales y de Género , Masculino , Humanos , Portugal/epidemiología , Homosexualidad Masculina , Brotes de Enfermedades , Análisis por Conglomerados
3.
BMJ Case Rep ; 15(9)2022 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-36127037

RESUMEN

We report the case of a man in his 40s who presented to our emergency department with a history of fever and a red, swollen and painful neck mass. Shortly following his birth, a congenital oesophageal atresia had been managed surgically with colonic interposition graft. Contrast CT of the neck revealed filling and distention of a colic stump with content of stasis and infection. The patient received intravenous piperacillin/tazobactam and parenteral nutrition. One week later, an upper digestive endoscopy was performed revealing an inflammatory-looking pseudopolypoid area immediately below the anastomosis, at the level of the proximal portion of the colon, which seemed to correspond to a complicated diverticulum with inflammation. The difficulties in reaching a definitive diagnosis and management of this condition are discussed.


Asunto(s)
Atresia Esofágica , Anastomosis Quirúrgica , Colon/diagnóstico por imagen , Colon/cirugía , Atresia Esofágica/complicaciones , Atresia Esofágica/cirugía , Humanos , Recién Nacido , Masculino , Piperacilina , Tazobactam
4.
Euro Surveill ; 27(22)2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35656830

RESUMEN

Up to 27 May 2022, Portugal has detected 96 confirmed cases of monkeypox. We describe 27 confirmed cases (median age: 33 years (range: 22-51); all males), with an earliest symptom onset date of 29 April. Almost all cases (n = 25) live in the Lisbon and Tagus Valley health region. Most cases were neither part of identified transmission chains, nor linked to travel or had contact with symptomatic persons or with animals, suggesting the possible previously undetected spread of monkeypox.


Asunto(s)
Monkeypox virus , Mpox , Brotes de Enfermedades , Humanos , Masculino , Mpox/diagnóstico , Mpox/epidemiología , Monkeypox virus/genética , Portugal/epidemiología , Viaje
5.
Port J Public Health ; 39(3): 137-144, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37753314

RESUMEN

Introduction: Health professionals face higher occupational exposure to SARS-CoV-2. We aimed to estimate the risk of COVID-19 test positivity in health professionals compared to non-health professionals. Methods: We conducted a test-negative case-control study using Portuguese national surveillance data (January to May 2020). Cases were suspected cases who tested positive for SARS-CoV-2; controls were suspected cases who tested negative. We used multivariable logistic regression modelling to estimate the odds ratio of a positive COVID-19 test (RT-PCR; primary outcome), comparing health professionals and non-health professionals (primary exposure), and adjusting for the confounding effect of demographic, clinical, and epidemiological characteristics, and the modification effect of the self-reported epidemiological link (i.e., self-reported contact with a COVID-19 case or person with COVID-19-like symptoms). Results: Health professionals had a 2-fold higher risk of a positive COVID-19 test result (aOR = 1.89, 95% CI 1.69-2.11). However, this association was strongly modified by the self-report of an epidemiological link such that, among cases who did report an epidemiological link, being a health professional was a protective factor (aOR = 0.90, 95% CI 0.82-0.98). Conclusion: Our findings suggest that health professionals might be primarily infected by unknown contacts, plausibly in the healthcare setting, but also that their occupational exposure does not systematically translate into a higher risk of transmission. We suggest that this could be interpreted in light of different types and timing of exposure, and variability in risk perception and associated preventive behaviours.


Introdução: Os profissionais de saúde têm uma maior exposição profissional à SARS-CoV-2. O objetivo era estimar o risco de testar positivo para SARS-CoV-2 em profissionais de saúde. Métodos: Foi realizado um estudo testenegativo caso-controlo utilizando os dados de vigilância epidemiológica nacional (Janeiro­Maio 2020). Casos foram definidos como casos suspeitos que testaram positivo para SARS-CoV-2 (RTPCR), e os controlos como casos suspeitos que testaram negativo. Foi aplicado um modelo de regressão logística multivariável para estimar o odds ratio de teste positivo para SARS-CoV-2, comparando profissionais de saúde e não profissionais de saúde, ajustado para as características demográficas, clínicas e epidemiológicas, e a modificação de efeito com o autorrelato duma ligação epidemiológica (i.e., contacto auto-reportado com um caso COVID-19 ou uma pessoa com sintomas semelhantes aos da COVID-19). Resultados: Os profissionais de saúde tiveram um risco duas vezes maior de testar positivo para SARS-CoV-2 (aOR = 1.89, 95% CI 1.69­2.11). No entanto, esta associação era fortemente modificada pelo autorrelato de uma ligação epidemiológica, de tal forma que entre os casos que relataram uma ligação epidemiológica, ser profissional de saúde revelou-se fator de proteção (aOR = 0.90, 95% CI 0.82­0.98). Conclusão: Os nossos resultados sugerem que os profissionais de saúde podem estar infetados principalmente por contactos desconhecidos, plausivelmente em instituições de saúde, e a exposição profissional não se traduz sistematicamente num maior risco de transmissão. Isto poderá ser interpretado à luz de diferentes tipos e tempos de exposição, e da variabilidade na perceção do risco e dos comportamentos preventivos associados.

6.
PLoS One ; 16(11): e0260249, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34797879

RESUMEN

COVID-19 mainly presents as a respiratory disease with flu-like symptoms, however, recent findings suggest that non-respiratory symptoms can occur early in the infection and cluster together in different groups in different regions. We collected surveillance data among COVID-19 suspected cases tested in mainland Portugal during the first wave of the pandemic, March-April 2020. A multivariable logistic-regression analysis was performed to ascertain the effects of age, sex, prior medical condition and symptoms on the likelihood of testing positive and hospitalisation. Of 25,926 COVID-19 suspected cases included in this study, 5,298 (20%) tested positive. Symptoms were grouped into ten clusters, of which two main ones: one with cough and fever and another with the remainder. There was a higher odds of a positive test with increasing age, myalgia and headache. The odds of being hospitalised increased with age, presence of fever, dyspnoea, or having a prior medical condition although these results varied by region. Presence of cough and other respiratory symptoms did not predict COVID-19 compared to non-COVID respiratory disease patients in any region. Dyspnoea was a strong determinant of hospitalisation, as well as fever and the presence of a prior medical condition, whereas these results varied by region.


Asunto(s)
COVID-19/epidemiología , Hospitalización/estadística & datos numéricos , Adulto , COVID-19/diagnóstico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Portugal
7.
Epidemiol Infect ; 149: e205, 2021 08 27.
Artículo en Inglés | MEDLINE | ID: mdl-34446124

RESUMEN

On 16-17 January 2020, four suspected mumps cases were reported to the local Public Health Authorities with an epidemiological link to a local school and football club. Of 18 suspected cases identified, 14 were included in this study. Laboratory results confirmed mumps virus as the cause and further sequencing identified genotype G. Our findings highlight that even with a high MMR vaccine coverage, mumps outbreaks in children and young adults can occur. Since most of the cases had documented immunity for mumps, we hypothesise that waning immunity or discordant mumps virus strains are likely explanations for this outbreak.


Asunto(s)
Brotes de Enfermedades , Vacuna contra el Sarampión-Parotiditis-Rubéola/administración & dosificación , Virus de la Parotiditis/inmunología , Paperas/epidemiología , Adolescente , Niño , Brotes de Enfermedades/prevención & control , Femenino , Genotipo , Humanos , Masculino , Vacuna contra el Sarampión-Parotiditis-Rubéola/genética , Vacuna contra el Sarampión-Parotiditis-Rubéola/inmunología , Paperas/prevención & control , Paperas/virología , Virus de la Parotiditis/genética , Virus de la Parotiditis/patogenicidad , Portugal/epidemiología , Vacunación/estadística & datos numéricos , Adulto Joven
9.
Euro Surveill ; 23(20)2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29790461

RESUMEN

A measles outbreak has been occurring in a healthcare setting in Porto, Portugal, since early March 2018, posing public health challenges for a central hospital and the community. Up to 22 April, 96 cases were confirmed, 67 in vaccinated healthcare workers, mostly between 18-39 years old. Following identification of the first cases, control measures were rapidly implemented. Concomitantly, other measles cases were notified in the Northern Region of the country. No common epidemiological link was identified.


Asunto(s)
Control de Enfermedades Transmisibles/métodos , Enfermedades Transmisibles Importadas , Brotes de Enfermedades/prevención & control , Vacuna Antisarampión/administración & dosificación , Virus del Sarampión/genética , Virus del Sarampión/aislamiento & purificación , Sarampión/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Enfermedades Transmisibles Importadas/epidemiología , Enfermedades Transmisibles Importadas/prevención & control , Notificación de Enfermedades , Femenino , Personal de Salud/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Masculino , Notificación Obligatoria , Sarampión/prevención & control , Sarampión/virología , Virus del Sarampión/inmunología , Persona de Mediana Edad , Exposición Profesional , Portugal/epidemiología , Salud Pública , Centros de Atención Terciaria , Vacunación/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...